SAILIFEBSESai Life Sciences Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 23 Jun, 2025 · 16:48 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TPG Asia VII SF Pte Ltd

Fii Holding Above 10pctFii Holding DeclinedOwnership Changes View source PDFExplain this filing

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.0%Reaction day
₹751.50
prior close
₹754.30
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.8%-1.8% vs market
Pharmaceuticals peers, median of 151sector+0.4%-1.4% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Smallcap 250 and 1.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.2
10m
-1.0
15m
-1.2
30m
-1.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.0+0.8-1.8+0.4-1.4
Next day
+0.7+2.4-1.7+1.7-1.0
2d
-0.1+2.7-2.7+1.3-1.4
3d
+1.1+3.5-2.4+1.8-0.7
4d
+2.9+4.4-1.5+3.0-0.1
5d
+3.8+4.2-0.4+2.8+1.0
1w
+5.2+4.2+1.0+3.1+2.1
15d
+7.9+5.3+2.6+4.7+3.2
1m
+10.4+4.0+6.4+3.6+6.8
2m
+20.5+0.1+20.5-1.1+21.7
3m
+18.9+0.7+18.3+0.6+18.3
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

TPG Asia VII SF Pte. Ltd, a Singapore-based private equity investor (not a promoter), sold 2,08,41,439 equity shares of Sai Life Sciences Ltd (face value ₹1 each) through an on-market transaction on June 20, 2025. This represents 10.00% of the company's total issued and paid-up equity share capital. After the sale, TPG's holding in Sai Life Sciences has come down from 5,15,48,272 shares (24.73%) to 3,07,06,833 shares (14.73%). The disclosure was filed on June 23, 2025 under SEBI's takeover regulations. No encumbrance or pledge-related activity is involved in this transaction.

Likely market impact

This is a significant FII sell-down by one of the company's largest institutional shareholders, which may put short-term pressure on the stock. However, TPG continues to hold a substantial 14.73% stake, indicating it is a partial exit rather than a complete departure.